Compare Medpace Holdings Inc (MEDP) vs ON Holding AG (ONON) Price & Performance

MEDP trades at $600.00, down 0.4% on the day, with a bullish technical signal driven by moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $4.25, and raised full-year guidance. Revenue growth is robust, with 2026 projected at $2.8 billion, though valuation multiples like a P/E of 35.58 and P/B of 38.95 are elevated. Net cash flow is expected to turn positive in 2026, and institutional activity is mixed, with some funds increasing stakes while others trim positions.

Outlook is positive due to earnings momentum and record bookings, but risks include high valuation sensitivity and a shareholder lawsuit investigation. Analyst consensus is a $599.57 price target with a 'Hold' bias, suggesting limited near-term upside from current levels amid growth-priced expectations.

ONON stock plunged 19.93% to $31.05 after Q2 2026 results, driven by a revenue miss and lowered full-year growth guidance. Despite beating EPS estimates in recent quarters, the company faces wholesale channel softness and cautious consumer spending. Technical indicators are bearish, with the price near key support at $30, while fundamentals show strong profitability margins and positive cash flow trends. Analyst sentiment remains largely bullish with a $52.86 consensus target, but near-term volatility persists.

The outlook is mixed: long-term growth potential exists via direct-to-consumer strength and margin expansion, but investors face risks from guidance uncertainty and competitive pressures. The sharp sell-off may present a buying opportunity for patient investors, though volatility could continue until wholesale trends stabilize.